Amulet Management Team
Chairman and Chief Executive Officer – Craig M Liddell, PhD
Dr Liddell is a successful entrepreneur with over 20 years experience in biotech, pharmaceuticals and academia. A former tenured professor, Dr Liddell has served as VP and CSO of Paradigm Genetics Inc, Artesian Therapeutics, Inc. a heart failure drug development company and BioFortis, Inc. a translational medicine software company.
Chief Financial Officer, Secretary and Treasurer – Jonathan Proch, CPA, MBA
Mr. Proch is a seasoned financial veteran whose successful career has spanned 24 years. Mr. Proch’s experience includes serving as CFO of Artesian Therapeutics, Inc. a heart failure drug development company, VP Finance for a chain of privately owned hospitals and CFO of a $35 million electronics company. Mr. Proch has raised substantial capital in these and other capacities.
Chief Operating Officer – Hank Dietz, MBA
Hank Dietz’ career has encompassed over 25 years in the Information Technology field spanning all aspects; from operations, application programming, systems programming, network management and design including systems administration and extensive management in both project work and supervision of technical staff. He has extensive laboratory management experience along with major system’s design and implementation for three startup biotech companies.
VP, Pharmacology – Robert Raulli, PhD, MSSTC
Dr Raulli is an experienced scientist/entrepreneur and founder of Amulet Pharmaceuticals Inc. He also co-founded a spin-out company (NOXILIZER, Inc) to commercialize sterilization technology developed at Amulet.
VP, Chemistry – Ralph Scannell, PhD
Dr. Scannell has more than 20 years of experience in the pharmaceutical/biotechnology industry where he held several leadership roles in drug discovery and development in multiple therapeutic areas.
Senior Director, Product Development - Maria Charest, MBA, PMP
Ms. Charest has amassed over 20 years experience in medical product development, about half of which has been in drug development. Most recently as Director of Project Planning and Management at MGI Pharma, she focused on early stage programs and has aggressively moved a number of lead compounds out of research and into the clinic.
Counsel: Samuel (Sandy) B. Sterrett, Jr., Partner, Foley & Lardner, LLP, Washington, D.C. (www.foley.com).
Amulet Board Of Directors
- Craig M Liddell, PhD Chairman and Chief Executive Officer
- Robert Raulli, PhD, MSSTC VP and Founder
- Carlos Parajon Managing Partner, Harbor Island Equity Partners, LLC
- Michael Cain Managing Member, Wilmington Investor Network LLC
Amulet Board Advisors
- Pankaj J. (Jay) Pasricha, MD Chief, Division of Gastroenterology and Hepatology, Stanford University
- Gianrico Farrugia, MD Director of the Enteric Neuroscience Program, Mayo Clinic
- Michael Horowitz, MD Chairman, Medicine University of Adelaide
- Richard Gillis, PhD Professor, Autonomic Pharmacology Georgetown
- Harry Mandeville, PhD CEO, Lipid BioSystems Inc.
- Joseph Verbalis, MD Chief of Medicine, Georgetown University Hospital